异动解读｜ARK Genomic Revolution ETF盘中下跌8.04%，木头姐近期减持Tempus AI拖累AI医疗主题情绪

10月31日，ARK Genomic Revolution ETF盘中下跌8.04%，报50.68美元，成交额4.27亿美元。

近期消息面上，Cathie Wood旗下ARK投资管理公司10月29日披露减持医疗AI公司Tempus AI，出售7625股，价值约58万美元；而在此前，Tempus AI虽接连获得欧盟认证、与百时美施贵宝及Pathos AI合作推进阿尔茨海默病药物研发，并扩展与Moderna、默沙东的个体化癌症疗法合作，但板块交易情绪仍偏谨慎。作为聚焦基因组革命主题的主动型ETF，ARKG短线随相关持仓与AI医疗概念走弱承压。

ARKG is an actively managed ETF that seeks long-term growth of capital by investing under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including health care, information technology, materials, energy and consumer discretionary, that are relevant to the Fund’s investment theme of the genomics revolution.

（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）